Division of Haematology

Haematology, the study of blood, is a broad-based science encompassing pathology, immunology, molecular biology and clinical medicine. Many human diseases are directly or indirectly related to abnormalities of blood cells. We work closely with the other divisions in research and clinical service.

Head of Division Dr. Raymond SM Wong, Consultant
Clinical Staff Dr. MF Law, Associate Consultant
Dr. Tommy HC Tam, Resident Specialist
Dr. Carmen KM Cheung, Resident
Dr. Jennifer WY Lai, Resident
Nursing Staff Lydia WK Lam
Research Staff Fion YF Choy
Ella Ng
Candy LS Tsang

Research Interests

  • Autoimmune haematological diseases
  • Leukemias, lymphomas and multiple myeloma
  • Bleeding, thrombosis and anticoagulant therapy
  • Transfusion medicine

Selected Publications

  1. Dunkley S, Lam JCM, John MJ, Wong RSM, Tran H, Yang R, Nair SC, Shima M, Street A, Srivastava A; Asia-Pacific Haemophilia Working Group (APHWG). Principles of haemophilia care: The Asia-Pacific perspective. Haemophilia. 2018 May;24(3):366-375.

  2. Wong RSM. Unicentric Castleman Disease. Hematol Oncol Clin North Am. 2018 Feb;32(1):65-73.

  3. Wong RSM, Saleh MN, Khelif A, Salama A, Portella MSO, Burgess P, Bussel JB. Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study. Blood. 2017 Dec 7;130(23):2527-2536. doi: 10.1182/blood-2017-04-748707. Epub 2017 Oct 17.

  4. Mittelman M, Platzbecker U, Afanasyev B, Grosicki S, Wong RSM, Anagnostopoulos A, Brenner B, Denzlinger C, Rossi G, Nagler A, Garcia-Delgado R, Portella MSO, Zhu Z, Selleslag D. Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial. Lancet Haematol. 2018 Jan;5(1):e34-e43.

  5. Lam WKJ, Gai W, Sun K, Wong RSM, Chan RWY, Jiang P, Chan NPH, Hui WWI, Chan AWH, Szeto CC, Ng SC, Law MF, Chan KCA, Chiu RWK, Lo YMD. DNA of Erythroid Origin Is Present in Human Plasma and Informs the Types of Anemia. Clin Chem. 2017 Oct;63(10):1614-1623.

  6. Brynes RK, Wong RS, Thein MM, Bakshi KK, Burgess P, Theodore D, Orazi A. A 2-Year, Longitudinal, Prospective Study of the Effects of Eltrombopag on Bone Marrow in Patients with Chronic Immune Thrombocytopenia. Acta Haematol. 2017;137(2):66-72.

  7. Chuncharunee S, Wong R, Rojnuckarin P, Chang CS, Chang KM, Lu MY, Hwang WL, Koh LP, Chen TY, Leung AY, Norasetthada L, Wang SC, Chang MC, Wu KH, Issaragrisil S. Efficacy of rabbit antithymocyte globulin as first-line treatment of severe aplastic anemia: an Asian multicenter retrospective study. Int J Hematol. 2016 Oct;104(4):454-61.

  8. Platzbecker U, Wong RS, Verma A, Abboud C, Araujo S, Chiou TJ, Feigert J, Yeh SP, Götze K, Gorin NC, Greenberg P, Kambhampati S, Kim YJ, Lee JH, Lyons R, Ruggeri M, Santini V, Cheng G, Jang JH, Chen CY, Johnson B, Bennett J, Mannino F, Kamel YM, Stone N, Dougherty S, Chan G, Giagounidis A. Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial. Lancet Haematol. 2015 Oct;2(10):e417-26.

  9. Wong RS, Bakshi K, Brainsky A. Thrombophilia in patients with chronic immune thrombocytopenia. Scand J Clin Lab Invest. 2015 Jan;75(1):13-7.

  10. van Rhee F, Wong RS, Munshi N, Rossi JF, Ke XY, Fosså A, Simpson D, Capra M, Liu T, Hsieh RK, Goh YT, Zhu J, Cho SG, Ren H, Cavet J, Bandekar R, Rothman M, Puchalski TA, Reddy M, van de Velde H, Vermeulen J, Casper C. Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2014 Aug;15(9):966-74.